Abstract
A third COVID-19 vaccine has been authorised for temporary supply in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the required standards of safety, efficacy and quality. The mRNA vaccine developed by Moderna, which has already been granted a conditional marketing authorisation in the EU, was found to be 94% effective in preventing […]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
